Reducing Post-Letermovir CMV Infection: Efficacy of an Immune-Reconstitution-Based Scoring System to Guide Prophylaxis Duration (clinicaltrials.gov) - Mar 3, 2026 - P=N/A | N=1114 | Not yet recruiting | Sponsor: Institute of Hematology & Blood Diseases Hospital, China
New trial • Cytomegalovirus Infection • Infectious Disease
|